Despite this, many rare disease trials continue to rely on a single outcome to assess efficacy and determine success or failure. While multiple outcomes are collected, they typically play limited or ...
In this review, we will discuss current NET classification and available drug therapies, recent advances in NET translational medicine, use of radiolabeled therapies for NETs, and best practices for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results